[go: up one dir, main page]

CN109293507B - Synthetic method and application of dimethyl 4-methoxymethylene-2-eneglutarate - Google Patents

Synthetic method and application of dimethyl 4-methoxymethylene-2-eneglutarate Download PDF

Info

Publication number
CN109293507B
CN109293507B CN201811191203.8A CN201811191203A CN109293507B CN 109293507 B CN109293507 B CN 109293507B CN 201811191203 A CN201811191203 A CN 201811191203A CN 109293507 B CN109293507 B CN 109293507B
Authority
CN
China
Prior art keywords
dimethyl
pentenedioate
reaction
synthesis
synthesizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811191203.8A
Other languages
Chinese (zh)
Other versions
CN109293507A (en
Inventor
张越
吴晓东
肖园
冯雪
陈爱兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lansheng Biotechnology Group Co ltd
Original Assignee
Hebei University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei University of Science and Technology filed Critical Hebei University of Science and Technology
Priority to CN201811191203.8A priority Critical patent/CN109293507B/en
Publication of CN109293507A publication Critical patent/CN109293507A/en
Application granted granted Critical
Publication of CN109293507B publication Critical patent/CN109293507B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种4‑甲氧基甲烯基‑2‑戊烯二酸二甲酯的合成方法,是以3‑甲氧基丙烯酸甲酯为原料,适当的碱性条件下,经过自身缩合反应,合成目标产物;本发明还公开了相应产物的一种应用。本发明所提供的合成方法操作简单,过程易于控制,所得4‑甲氧基甲烯基‑2‑戊烯二酸二甲酯的收率为65.5%,所制得的4‑甲氧基甲烯基‑2‑戊烯二酸二甲酯的两种应用,一是能作为标准品,用于检测和监控氟啶虫酰胺及其中间体的合成,二则是用于合成N,N‑二(4‑甲氧羰基‑2,4‑戊二烯酸甲酯‑5‑)氮烷。The invention discloses a method for synthesizing dimethyl 4-methoxymethenyl-2-glutaconate. The method uses methyl 3-methoxyacrylate as a raw material, and under appropriate alkaline conditions, the A condensation reaction is performed to synthesize the target product; the invention also discloses an application of the corresponding product. The synthesis method provided by the invention is simple to operate, and the process is easy to control, the yield of the obtained dimethyl 4-methoxymethyl-2-glutamate is 65.5%, and the prepared 4-methoxymethyl Two applications of dimethyl alkenyl-2-glutamate, one is as a standard to detect and monitor the synthesis of flonicamid and its intermediates, and the other is for the synthesis of N,N- Bis(4-methoxycarbonyl-2,4-methylpentadienoate-5-)azane.

Description

4-甲氧基甲烯基-2-烯戊二酸二甲酯的合成方法及其应用Synthetic method and application of dimethyl 4-methoxymethylene-2-eneglutarate

技术领域technical field

本发明属于制药领域,涉及一种药物中间体的合成方法,具体地说,是4-甲氧基甲烯基-2-戊烯二酸二甲酯的合成方法及其应用。The invention belongs to the field of pharmacy, and relates to a method for synthesizing a pharmaceutical intermediate, in particular to a method for synthesizing dimethyl 4-methoxymethyl-2-pentenedioate and its application.

背景技术Background technique

4-甲氧基甲烯基-2-戊烯二酸二甲酯是一种重要的药物中间体,用于合成如烟碱型乙酰胆碱受体激动剂吡啶酮类衍生物、拟钙剂以及新型杀虫剂等,也被发现是农药氟啶虫酰胺(flonicamid)合成过程中的杂质。Dimethyl 4-methoxymethylene-2-pentenedioate is an important pharmaceutical intermediate for the synthesis of pyridone derivatives such as nicotinic acetylcholine receptor agonists, calcimimetic agents and new Insecticides, etc., have also been found to be impurities in the synthesis of the pesticide flonicamid.

据文献(Synthetic Communications, 1987, Vol.17,No.7, 761-771)报道,4-甲氧基甲烯基-2-戊烯二酸二甲酯可以采用香豆酸和甲醇在酸性条件下发生开环反应的方法制备,反应式如下:According to the literature (Synthetic Communications, 1987, Vol.17, No.7, 761-771), dimethyl 4-methoxymethylene-2-pentenedioate can be prepared using coumaric acid and methanol under acidic conditions. The method preparation of ring-opening reaction occurs below, and the reaction formula is as follows:

Figure 559185DEST_PATH_IMAGE001
Figure 559185DEST_PATH_IMAGE001

香豆酸首先发生酯化反应,然后再经历12h的回流后可以开环得到4-甲氧基甲烯基-2-戊烯二酸二甲酯,收率48%,仍然有12%的香豆酸甲酯剩余;当采用1:3倍量的甲醇:原甲酸三甲酯对香豆酸开环后,历经48h可以得到89%的4-甲氧基甲烯基-2-戊烯二酸二甲酯并且生成上式中的加成杂质c,大比例原甲酸三甲酯的使用不仅给分离带来了困难,而且对环境的污染也很大。后期虽然有更多的研究者进行了改进(US8791147;US8952165;Bull.Korean Chem. Soc. 2001, Vol. 22, No. 2,234-236;Phosphorus, Sulfur, andSilicon, 2008,Vol.183,3145–3155),也都是基于香豆酸和甲醇的开环反应,反应式如下:Coumaric acid first undergoes an esterification reaction, and then undergoes 12h of reflux to open the ring to obtain dimethyl 4-methoxymethylene-2-pentenedioate, with a yield of 48% and still 12% of the fragrance. Methyl stearate remains; when using 1:3 times the amount of methanol: trimethyl orthoformate to open the ring of coumaric acid, 89% of 4-methoxymethylene-2-pentenedi can be obtained after 48h dimethyl orthoformate and the addition impurity c in the above formula is generated. The use of a large proportion of trimethyl orthoformate not only brings difficulties to the separation, but also causes great pollution to the environment. Although more researchers have made improvements later (US8791147; US8952165; Bull.Korean Chem.Soc. 2001, Vol. 22, No. 2, 234-236; Phosphorus, Sulfur, and Silicon, 2008, Vol.183, 3145 –3155), also based on the ring-opening reaction of coumaric acid and methanol, the reaction formula is as follows:

Figure 7484DEST_PATH_IMAGE002
Figure 7484DEST_PATH_IMAGE002

虽然采用等比例的乙酰氯催化香豆酸开环合成4-甲氧基甲烯基-2-戊烯二酸二甲酯,反应时间仍然很长(≥10h),去掉了加成杂质,但是12%新的异构体杂质生成了(a:b=7.3:1),产物为混合物。而且,上述方法采用植物提取的香豆酸为原料,价格较昂贵,反应时间长(10~48h)。Although an equal proportion of acetyl chloride is used to catalyze the ring-opening synthesis of dimethyl 4-methoxymethylene-2-pentenedioate with coumaric acid, the reaction time is still very long (≥10h), and the addition impurities are removed, but 12% of new isomer impurities were formed (a:b=7.3:1) and the product was a mixture. Moreover, the above method uses coumaric acid extracted from plants as a raw material, which is expensive and has a long reaction time (10-48h).

发明内容SUMMARY OF THE INVENTION

本发明要解决的技术问题,是提供一种4-甲氧基甲烯基-2-戊烯二酸二甲酯的合成方法,旨在以更加易得的工业原料3-甲氧基丙烯酸甲酯为原料,在适当的条件下,经过缩合反应,3h之内合成4-甲氧基甲烯基-2-戊烯二酸二甲酯,力求合成方法过程简单,易于控制,并具有较高的收率;The technical problem to be solved by the present invention is to provide a synthetic method of dimethyl 4-methoxymethylene-2-glutamate, aiming at using a more readily available industrial raw material, methyl 3-methoxyacrylate Ester as raw material, under appropriate conditions, through condensation reaction, 4-methoxymethylene-2-pentenedioic acid dimethyl ester is synthesized within 3h, and the synthesis method is simple, easy to control, and has high yield;

本发明的另外一个目的,是提供4-甲氧基甲烯基-2-戊烯二酸二甲酯的一种应用,该化合物除作为中间体用于药物合成用途以外,还可以用于监控氟啶虫酰胺及其中间体的合成过程中;Another object of the present invention is to provide a kind of application of dimethyl 4-methoxymethylene-2-pentenedioate, the compound can be used for monitoring and controlling in addition to being used as an intermediate for pharmaceutical synthesis During the synthesis of flonicamid and its intermediates;

本发明的第三个目的,是要提供4-甲氧基甲烯基-2-戊烯二酸二甲酯的第二种应用,即用于合成N,N-二(4-甲氧羰基-2,4-戊二烯酸甲酯-5-)氮烷。The third object of the present invention is to provide the second application of dimethyl 4-methoxymethylene-2-pentenedioate, namely for the synthesis of N,N-bis(4-methoxycarbonyl -2,4-Methyl pentadienoate-5-)azane.

为实现上述发明目的,本发明所采用的技术方案是:For realizing the above-mentioned purpose of the invention, the technical scheme adopted in the present invention is:

一种4-甲氧基甲烯基-2-戊烯二酸二甲酯的合成方法,它以3-甲氧基丙烯酸甲酯为原料,在碱催化下经过自身缩合反应生成4-甲氧基甲烯基-2-戊烯二酸二甲酯。A method for synthesizing dimethyl 4-methoxymethyl-2-glutarate, which uses methyl 3-methoxyacrylate as a raw material, and generates 4-methoxyl through self-condensation reaction under alkali catalysis Dimethyl methylenyl-2-pentenedioate.

作为本发明的限定,上述合成方法的反应路线如下:As limitation of the present invention, the reaction scheme of above-mentioned synthetic method is as follows:

Figure 911855DEST_PATH_IMAGE003
Figure 911855DEST_PATH_IMAGE003

作为本发明的进一步限定,上述合成方法按照如下步骤顺序进行:As a further limitation of the present invention, the above-mentioned synthetic method is carried out in the following order of steps:

将催化剂碱加入溶剂中,搅拌均匀随后将3-甲氧基丙烯酸甲酯加入,于适合温度下反应,反应完成后得反应液A;过滤反应液A得滤液B;将滤液B加至冰水中淬灭反应,萃取并浓缩有机相,柱色谱法分离,即得4-甲氧基甲烯基-2-戊烯二酸二甲酯,为白色固体颗粒。The catalyst base is added to the solvent, and then the methyl 3-methoxyacrylate is added, reacted at a suitable temperature, and the reaction solution A is obtained after the reaction is completed; the reaction solution A is filtered to obtain a filtrate B; the filtrate B is added to the ice water The reaction was quenched, the organic phase was extracted and concentrated, and separated by column chromatography to obtain dimethyl 4-methoxymethylene-2-pentenedioate as white solid particles.

作为本发明的更进一步限定:As a further limitation of the present invention:

所述的碱可以是甲醇钠、乙醇钠、甲醇钾或氢氧化钠,优选为甲醇钠或甲醇钾;Described alkali can be sodium methoxide, sodium ethoxide, potassium methoxide or sodium hydroxide, preferably sodium methoxide or potassium methoxide;

反应中所用碱量与3-甲氧基丙烯酸甲酯用量的当量比为0.5~5:1,优选1.5~2.5:1;The equivalent ratio of the amount of base used in the reaction to the amount of methyl 3-methoxyacrylate is 0.5 to 5:1, preferably 1.5 to 2.5:1;

所述的溶剂可以是THF、DMF、DMAC、甲醇或乙腈,优选DMF或DMAC;The solvent can be THF, DMF, DMAC, methanol or acetonitrile, preferably DMF or DMAC;

反应温度可以是20~80℃,优选35~40℃。The reaction temperature may be 20 to 80°C, preferably 35 to 40°C.

本发明还提供了前述制备方法所制4-甲氧基甲烯基-The present invention also provides 4-methoxymethenyl-

2-戊烯二酸二甲酯的一种应用,它可以作为标准品,用于检测和监控氟啶虫酰胺及其中间体的合成。An application of dimethyl 2-pentenedioate, which can be used as a standard to detect and monitor the synthesis of flonicamid and its intermediates.

本发明也提供了前述制备方法所制4-甲氧基甲烯基-2-戊烯二酸二甲酯的另一种应用,它用于合成N,N-二(4-甲氧羰基-2,4-戊二烯酸甲酯-5-)氮烷。The present invention also provides another application of dimethyl 4-methoxymethylene-2-pentenedioate prepared by the aforementioned preparation method, which is used for synthesizing N,N-bis(4-methoxycarbonyl- Methyl 2,4-pentadienoate-5-)azane.

本发明由于采用了上述的技术方案,其与现有技术相比,所取得的技术进步在于:Because the present invention adopts the above-mentioned technical scheme, compared with the prior art, the technical progress achieved is:

本发明提供的合成方法,可以采用工业化原料3-甲氧基丙烯酸甲酯为原料,经过简单的缩合反应,在短时间内合成4-甲氧基甲烯基-2-戊烯二酸二甲酯,未检测到异构体和加成杂质,操作过程简单,易于控制,产品收率可高达65.5%。The synthesis method provided by the invention can use the industrialized raw material 3-methoxyacrylate methyl ester as the raw material, and through a simple condensation reaction, 4-methoxymethylene-2-glutaconate dimethyl can be synthesized in a short time Esters, isomers and addition impurities are not detected, the operation process is simple and easy to control, and the product yield can be as high as 65.5%.

本发明的制备方法适用于合成4-甲氧基甲烯基-2-戊烯二酸二甲酯,所制备的合成物能用于检测和监控氟啶虫酰胺及其中间体的合成,也可用于合成N,N-二(4-甲氧羰基-2,4-戊二烯酸甲酯-5-)氮烷。The preparation method of the invention is suitable for synthesizing dimethyl 4-methoxymethylene-2-pentenedioate, the prepared compound can be used for detecting and monitoring the synthesis of flonicamid and its intermediates, and also It can be used to synthesize N,N-two (4-methoxycarbonyl-2,4-pentadienoic acid methyl ester-5-) azane.

本发明下面将结合具体实施例作进一步详细说明。The present invention will be described in further detail below with reference to specific embodiments.

附图说明Description of drawings

图1为4-甲氧基甲烯基-2-戊烯二酸二甲酯的1HNMR图;Fig. 1 is the 1 HNMR chart of dimethyl 4-methoxymethylene-2-pentenedioate;

图2为4-甲氧基甲烯基-2-戊烯二酸二甲酯的13CNMR图;Fig. 2 is the 13 CNMR chart of dimethyl 4-methoxymethylene-2-pentenedioate;

图3为4-甲氧基甲烯基-2-戊烯二酸二甲酯的液相图(波长288nm);Figure 3 is a liquid phase diagram of dimethyl 4-methoxymethyl-2-pentenedioate (wavelength 288 nm);

图4为某工厂制备的氟啶虫酰胺液相图;Fig. 4 is the liquid phase diagram of flonicamid prepared by a factory;

图5为4-甲氧基甲烯基-2-戊烯二酸二甲酯液相图(波长265nm);Figure 5 is a liquid phase diagram of dimethyl 4-methoxymethylene-2-pentenedioate (wavelength 265 nm);

图6为某工厂合成的中间体N-(2-甲氧基羰基乙烯基)-4,4,4-三氟-3-酮-1-丁烯胺的液相图。Figure 6 is a liquid phase diagram of the intermediate N-(2-methoxycarbonylvinyl)-4,4,4-trifluoro-3-one-1-butenamine synthesized in a factory.

具体实施方式Detailed ways

下述实施例中所用的试剂如无特殊说明均为现有市售试剂,试验方法如无特殊说明均采用现有的试验方法。The reagents used in the following examples are all existing commercially available reagents unless otherwise specified, and the existing test methods are used for the test methods unless otherwise specified.

实施例1 4-甲氧基甲烯基-2-戊烯二酸二甲酯的一种合成方法Embodiment 1 A kind of synthetic method of 4-methoxymethylene-2-pentenedioic acid dimethyl ester

Figure 838223DEST_PATH_IMAGE003
Figure 838223DEST_PATH_IMAGE003

于室温下向80mL的N,N-二甲基甲酰胺(溶剂)中加入5.4g甲醇钠(碱,作为催化剂),开启搅拌成混悬状,一次性加入3-甲氧基丙烯酸甲酯11.6g,缓慢升温至35 ℃,并控温35~40℃,3h。反应完成后,过滤,将滤液加入至250mL冰水中,用乙酸乙酯萃取,无水硫酸钠干燥,浓缩为粘稠液状物。柱层析分离得到白色固体,即为4-甲氧基甲烯基-2-戊烯二酸二甲酯,其相关检测数据参见图1~图2。Add 5.4 g of sodium methoxide (base, as a catalyst) to 80 mL of N,N-dimethylformamide (solvent) at room temperature, turn it on and stir to form a suspension, and add 11.6 g of methyl 3-methoxyacrylate at one time. g, slowly heat up to 35 °C, and control the temperature to 35 to 40 °C for 3 h. After the reaction was completed, filtered, the filtrate was added to 250 mL of ice water, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and concentrated into a viscous liquid. A white solid was obtained by column chromatography, which was dimethyl 4-methoxymethylene-2-pentenedioate, and the relevant detection data were shown in Fig. 1 to Fig. 2 .

实施例2 4-甲氧基甲烯基-2-戊烯二酸二甲酯的一种合成方法Embodiment 2 A kind of synthetic method of 4-methoxymethylene-2-pentenedioic acid dimethyl ester

Figure 183753DEST_PATH_IMAGE003
Figure 183753DEST_PATH_IMAGE003

于室温下向50mL的N,N-二甲基乙酰胺(溶剂)中加入4.3g甲醇钾(碱,作为催化剂),开启搅拌成混悬状,加入3-甲氧基丙烯酸甲酯10g,室温反应3h。反应完成后,过滤,将滤液加入至200mL冰水中,用乙酸乙酯萃取,加无水硫酸钠干燥,浓缩为粘稠液状物。经柱层析分离得到白色固体,即为4-甲氧基甲烯基-2-戊烯二酸二甲酯。Add 4.3 g of potassium methoxide (base, as a catalyst) to 50 mL of N,N-dimethylacetamide (solvent) at room temperature, turn on and stir to form a suspension, add 10 g of methyl 3-methoxyacrylate, room temperature The reaction was carried out for 3 hours. After the reaction is completed, filter, add the filtrate into 200 mL of ice water, extract with ethyl acetate, add anhydrous sodium sulfate, dry, and concentrate to a viscous liquid. A white solid was obtained by column chromatography, which was dimethyl 4-methoxymethylene-2-pentenedioate.

实施例3~8 4-甲氧基甲烯基-2-戊烯二酸二甲酯的合成方法Embodiment 3~8 The synthetic method of 4-methoxymethylene-2-pentenedioic acid dimethyl ester

Figure 537374DEST_PATH_IMAGE003
Figure 537374DEST_PATH_IMAGE003

实施例3~8分别为一种4-甲氧基甲烯基-2-戊烯二酸二甲酯的合成方法,它们的操作步骤均与实施例1、实施例2相似,仅仅是反应物的种类、用量,以及过程中的控制参数、产品的收率等不同,且目标产物通过采用正己烷/乙酸乙酯进行重结晶的方式实现提离。实施例3~8的相关参数具体见下表:Embodiments 3 to 8 are respectively a kind of synthetic method of dimethyl 4-methoxymethylene-2-pentenedioate, and their operation steps are all similar to those of embodiment 1 and embodiment 2, and are only reactants The type and dosage of the product, as well as the control parameters in the process, the yield of the product, etc. are different, and the target product is separated by recrystallization using n-hexane/ethyl acetate. The relevant parameters of Examples 3 to 8 are shown in the following table:

Figure 335566DEST_PATH_IMAGE004
Figure 335566DEST_PATH_IMAGE004

实施例9 4-甲氧基甲烯基-2-戊烯二酸二甲酯的一种应用Embodiment 9 A kind of application of dimethyl 4-methoxymethyl-2-pentenedioate

氟啶虫酰胺的合成路线如下所示,由乙烯基乙醚经三氟乙酰化、氨解、缩合、环化、酰氯化和酰胺化反应最终合成氟啶虫酰胺。The synthetic route of flonicamid is shown below. The final synthesis of flonicamid is through trifluoroacetylation, aminolysis, condensation, cyclization, acid chlorination and amidation of vinyl ether.

Figure 534466DEST_PATH_IMAGE005
Figure 534466DEST_PATH_IMAGE005

在合成中间体N-(2-甲氧基羰基乙烯基)-4,4,4-三氟-3-酮-1-丁烯胺的过程中,出现了杂质4-甲氧基甲烯基-2-戊烯二酸二甲酯,因为较难除去,所以该杂质的存在不仅会影响中间体的质量,也会影响最终产品氟啶虫酰胺的质量。During the synthesis of the intermediate N-(2-methoxycarbonylvinyl)-4,4,4-trifluoro-3-one-1-butenamine, the impurity 4-methoxymethenyl appeared Dimethyl-2-pentenedioate, because it is difficult to remove, the existence of this impurity will not only affect the quality of the intermediate, but also affect the quality of the final product flonicamid.

本发明对实施例1~8所制的4-甲氧基甲烯基-2-戊烯二酸二甲酯提供了一种应用,即可以作为标准对照品检测氟啶虫酰胺及其中间体是否存在杂质4-甲氧基甲烯基-2-戊烯二酸二甲酯和其含量多少。此外在用上述方法合成氟啶虫酰胺中间体的过程中,可以用作标准品检测和监控此杂质的生成情况,这对反应条件的改进具有重要意义。The present invention provides an application to the dimethyl 4-methoxymethylene-2-pentenedioate prepared in Examples 1 to 8, that is, it can be used as a standard reference substance to detect flonicamid and its intermediates Whether there is an impurity dimethyl 4-methoxymethyl-2-pentenedioate and its content. In addition, in the process of synthesizing flonicamid intermediate by the above method, it can be used as a standard to detect and monitor the generation of this impurity, which is of great significance to the improvement of reaction conditions.

高效液相条件:HPLC conditions:

流动相:甲醇/水=60/40Mobile phase: methanol/water=60/40

检测波长:288 nmDetection wavelength: 288 nm

流速:1.0 mL/minFlow rate: 1.0 mL/min

4-甲氧基甲烯基-2-戊烯二酸二甲酯在该液相条件下的液相图见图3。The liquid phase diagram of dimethyl 4-methoxymethylene-2-pentenedioate under this liquid phase condition is shown in Fig. 3 .

图4为某工厂制备的氟啶虫酰胺液相图。Figure 4 is a liquid phase diagram of flonicamid prepared in a factory.

可以采用HPLC的方法检测氟啶虫酰胺的产品中是否含有杂质4-甲氧基甲烯基-2-戊烯二酸二甲酯。由图可以看出,本氟啶虫酰胺样品经检测不含有该杂质。The HPLC method can be used to detect whether the product of flonicamid contains the impurity dimethyl 4-methoxymethyl-2-pentenedioate. It can be seen from the figure that the flonicamid sample does not contain this impurity after testing.

高效液相条件:HPLC conditions:

流动相:甲醇/水=40/60Mobile phase: methanol/water=40/60

检测波长:265 nmDetection wavelength: 265 nm

流速:1.0 mL/minFlow rate: 1.0 mL/min

图5为4-甲氧基甲烯基-2-戊烯二酸二甲酯在该液相条件下的液相图。Figure 5 is a liquid phase diagram of dimethyl 4-methoxymethylene-2-pentenedioate under the liquid phase conditions.

某工厂合成的中间体N-(2-甲氧基羰基乙烯基)-4,4,4-三氟-3-酮-1-丁烯胺的液相图见图6。The liquid phase diagram of the intermediate N-(2-methoxycarbonylvinyl)-4,4,4-trifluoro-3-keto-1-butenamine synthesized in a factory is shown in Figure 6.

可以看出生产的中间体N-(2-甲氧基羰基乙烯基)-4,4,4-三氟-3-酮-1-丁烯胺中含有一定量的4-甲氧基甲烯基-2-戊烯二酸二甲酯杂质。It can be seen that the produced intermediate N-(2-methoxycarbonylvinyl)-4,4,4-trifluoro-3-keto-1-butenamine contains a certain amount of 4-methoxymethane Dimethyl-2-pentenedioate impurity.

实施例10 4-甲氧基甲烯基-2-戊烯二酸二甲酯的一种应用Embodiment 10 A kind of application of dimethyl 4-methoxymethylene-2-pentenedioate

本实施例提供了4-甲氧基甲烯基-2-戊烯二酸二甲酯的另一种应用,将它用于与氨气发生氨化反应,而合成N,N-二(4-甲氧羰基-2,4-戊二烯酸甲酯-5-)氮烷。其合成路线如下:This example provides another application of dimethyl 4-methoxymethylene-2-pentenedioate, which is used for the amination reaction with ammonia gas to synthesize N,N-bis(4 -Methoxycarbonyl-2,4-pentadienoate methyl-5-)azane. Its synthetic route is as follows:

Figure 734503DEST_PATH_IMAGE006
Figure 734503DEST_PATH_IMAGE006

4-甲氧基甲烯基-2-戊烯二酸二甲酯在常压下或正压下通入氨气,室温或稍加热情况下控温反应3~4h至反应完全,再加入4~5倍于溶剂容量的冰水中,冰水浴下搅拌28~35min,析出黄绿色固体小颗粒,过滤、干燥,即得N,N-二(4-甲氧羰基-2,4-戊二烯酸甲酯-5-)氮烷品。4-Methoxymethylene-2-pentenedioic acid dimethyl ester is introduced into ammonia gas under normal pressure or positive pressure, and the temperature is controlled to react for 3 to 4 hours at room temperature or slightly heated until the reaction is complete, and then add 4 ~5 times of the solvent capacity in ice water, stir under ice water bath for 28 ~ 35min, and precipitate small yellow-green solid particles, filter and dry to obtain N,N-bis(4-methoxycarbonyl-2,4-pentadiene) Methyl acid-5-)azane product.

实施例11 4-甲氧基甲烯基-2-戊烯二酸二甲酯的一种应用Embodiment 11 A kind of application of dimethyl 4-methoxymethylene-2-pentenedioate

本实施例提供了4-甲氧基甲烯基-2-戊烯二酸二甲酯的第三种应用,将它用于与原位生成氨气的化合物发生氨化反应,而合成N,N-二(4-甲氧羰基-2,4-戊二烯酸甲酯-5-)氮烷。其合成路线如下:The present embodiment provides a third application of dimethyl 4-methoxymethylene-2-pentenedioate, which is used for the ammoniation reaction with a compound that generates ammonia in situ to synthesize N, N-bis(4-methoxycarbonyl-2,4-pentadienoate methyl ester-5-)azane. Its synthetic route is as follows:

Figure 259026DEST_PATH_IMAGE006
Figure 259026DEST_PATH_IMAGE006

将能够原位生成氨气的化合物(比如(E)-4-氨基-1,1,1-三氟丁-3-烯-2-酮),溶解于溶剂后滴加进入盛有溶解于溶剂中的4-甲氧基甲烯基-2-戊烯二酸二甲酯中,控温,反应3~4h至反应完全,再加入4~5倍于溶剂容量的冰水中,冰水浴下搅拌28~35min,析出黄绿色固体小颗粒,过滤、干燥,即得N,N-二(4-甲氧羰基-2,4-戊二烯酸甲酯-5-)氮烷品。Compounds that can generate ammonia gas in situ (such as (E)-4-amino-1,1,1-trifluorobut-3-en-2-one) are dissolved in the solvent and added dropwise into the solvent In the dimethyl 4-methoxymethylene-2-pentenedioate in , the temperature is controlled, and the reaction is performed for 3 to 4 h until the reaction is complete, then add ice water with 4 to 5 times the solvent capacity, and stir in an ice water bath. After 28 to 35 minutes, small yellow-green solid particles were precipitated, filtered and dried to obtain N,N-bis(4-methoxycarbonyl-2,4-pentadienoic acid methyl ester-5-)azane product.

Claims (9)

1. A method for synthesizing 4-methoxy methyl alkenyl-2-glutaconic acid dimethyl ester is characterized in that: the synthesis method takes 3-methoxy methyl acrylate as a raw material, and the 4-methoxy methyl alkenyl-2-pentenedioic acid dimethyl ester is synthesized through the self-condensation reaction under the catalysis of alkali.
2. The method for synthesizing 4-methoxy methyl alkenyl-2-glutaconic acid dimethyl ester according to claim 1, wherein the synthetic route of the method is as follows:
Figure 152310DEST_PATH_IMAGE001
3. the method of synthesizing 4-methoxymethyllene-2-pentenedioic acid dimethyl ester according to claim 1 or 2, wherein: the synthesis method comprises the following steps in sequence:
adding alkali into a solvent, adding 3-methoxy methyl acrylate for reaction, and obtaining a reaction solution A after the reaction is finished;
filtering the reaction solution A to obtain a filtrate B;
adding the filtrate B into ice water to quench the reaction, extracting and concentrating an organic phase, and separating by column chromatography to obtain the 4-methoxy methyl alkenyl-2-pentenedioic acid dimethyl ester.
4. The method of synthesizing 4-methoxymethyllene-2-pentenedioic acid dimethyl ester according to claim 3, wherein: the alkali is sodium methoxide, sodium ethoxide, potassium methoxide or sodium hydroxide.
5. The method of claim 3, wherein the synthesis of dimethyl 4-methoxymethyllene-2-pentenedioate comprises: the equivalent ratio of the amount of the alkali used in the reaction to the amount of the methyl 3-methoxyacrylate is 0.5-5: 1.
6. The method of claim 3, wherein the synthesis of dimethyl 4-methoxymethyllene-2-pentenedioate comprises: the solvent is THF, DMF, DMAC, methanol or acetonitrile.
7. The method of claim 3, wherein the synthesis of dimethyl 4-methoxymethyllene-2-pentenedioate comprises: the reaction temperature is 20-80 ℃.
8. An application of the dimethyl 4-methoxymethyl ene-2-pentenedioate prepared by the method for synthesizing dimethyl 4-methoxymethyl ene-2-pentenedioate according to any one of claims 1 to 7, wherein the method comprises the following steps: the 4-methoxy methyl alkenyl-2-glutaconic acid dimethyl ester is used as a standard substance, and whether the impurity 4-methoxy methyl alkenyl-2-glutaconic acid dimethyl ester exists or not and the content of the impurity is detected by an HPLC method; and detecting and monitoring the generation condition of the impurities in the final synthesis process of flonicamid by the steps of trifluoroacetylation, ammonolysis, condensation, cyclization, acyl chlorination and amidation of vinyl ethyl ether.
9. An application of the dimethyl 4-methoxymethyl ene-2-pentenedioate prepared by the method for synthesizing dimethyl 4-methoxymethyl ene-2-pentenedioate according to any one of claims 1 to 7, wherein the method comprises the following steps: the 4-methoxy methyl alkenyl-2-pentenedioic acid dimethyl ester is used for synthesizing N, N-di (4-methoxycarbonyl-2, 4-pentadienoic acid methyl ester-5-) azane.
CN201811191203.8A 2018-10-12 2018-10-12 Synthetic method and application of dimethyl 4-methoxymethylene-2-eneglutarate Active CN109293507B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811191203.8A CN109293507B (en) 2018-10-12 2018-10-12 Synthetic method and application of dimethyl 4-methoxymethylene-2-eneglutarate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811191203.8A CN109293507B (en) 2018-10-12 2018-10-12 Synthetic method and application of dimethyl 4-methoxymethylene-2-eneglutarate

Publications (2)

Publication Number Publication Date
CN109293507A CN109293507A (en) 2019-02-01
CN109293507B true CN109293507B (en) 2020-12-18

Family

ID=65162568

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811191203.8A Active CN109293507B (en) 2018-10-12 2018-10-12 Synthetic method and application of dimethyl 4-methoxymethylene-2-eneglutarate

Country Status (1)

Country Link
CN (1) CN109293507B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101486684A (en) * 2009-02-20 2009-07-22 常熟华益化工有限公司 Preparation of 2,4-dichloro-5-methoxy pyrimidine
CN103328477A (en) * 2011-01-28 2013-09-25 爱思开生物制药株式会社 Pharmaceutical composition comprising pyridone derivatives
CN103339131A (en) * 2011-01-28 2013-10-02 爱思开生物制药株式会社 Pharmaceutical composition comprising pyridone derivatives

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101486684A (en) * 2009-02-20 2009-07-22 常熟华益化工有限公司 Preparation of 2,4-dichloro-5-methoxy pyrimidine
CN103328477A (en) * 2011-01-28 2013-09-25 爱思开生物制药株式会社 Pharmaceutical composition comprising pyridone derivatives
CN103339131A (en) * 2011-01-28 2013-10-02 爱思开生物制药株式会社 Pharmaceutical composition comprising pyridone derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
头孢布烯关键中间体7β位侧链的合成及结构表征;马红梅 等;《精细化工中间体》;20071015;第37 卷(第5 期);40-43 *

Also Published As

Publication number Publication date
CN109293507A (en) 2019-02-01

Similar Documents

Publication Publication Date Title
WO2015165320A1 (en) Regorafenib salt and crystal form thereof, and preparation method
JP7097467B2 (en) Bribalacetam intermediate, its manufacturing method and bribalacetam manufacturing method
CN104130195B (en) A kind of haptenic synthetic method of carbendazim
CN108658805B (en) Preparation method of asymmetric azobenzene
CN110396063A (en) A kind of preparation method of the miscellaneous Shandong amine of grace
CN109293507B (en) Synthetic method and application of dimethyl 4-methoxymethylene-2-eneglutarate
CN109384767B (en) Preparation method and intermediate of pyridopyrimidine derivative
CN109232254B (en) A kind of compound synthesis method and application
WO2020181860A1 (en) Method for preparing rivaroxaban intermediate
CN102659658A (en) Method for synthesis of highly functionalized pyrrole compound
CN104710413B (en) The preparation method of two maleic acid Afatinibs
CN107778224B (en) Preparation method of betrixaban intermediate
SK286717B6 (en) Process for preparing a substituted imidazopyridine compound
CN108033892A (en) A kind of preparation method of N- alkyl iminodiacetics acid
CN113582984A (en) Arotinolol hydrochloride impurity and preparation method and application thereof
CN107573263B (en) Synthetic method of omega-substituted biuret compound
CN114907283B (en) A preparation method of 2-(3,5-dichlorophenyl)-benzoxazole-6-carboxylic acid
CN110885315A (en) Preparation method of important intermediate of levosimendan
CN112341413A (en) Intermediate for synthesizing brivaracetam and preparation method thereof
CN106279114B (en) A kind of synthetic method of Taladegib
CN109942442A (en) A kind of preparation method of dapoxetine hydrochloride related substance I
CN110372774A (en) The alpha-acyloxy amides dipeptides analog derivative and synthetic method that isoindolone replaces
CN109438272A (en) The synthetic method of C5a receptor antagonist W-54011
CN110818676A (en) Crystal form of cyclohexane derivative
JP2020535192A (en) Crystal form of lenalidomide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20211125

Address after: 051430 Ma Yu Cun, Jinzhou City, Shijiazhuang City, Hebei Province

Patentee after: HEBEI LANSHENG BIOTECH Co.,Ltd.

Address before: 050000 26 Yuxiang Street, Shijiazhuang City, Hebei Province

Patentee before: HEBEI University OF SCIENCE AND TECHNOLOGY

CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 052260 No.1, Hongsheng Road West, Mayu Village, Mayu Township, Jinzhou City, Shijiazhuang City, Hebei Province

Patentee after: Lansheng Biotechnology Group Co.,Ltd.

Address before: 051430 Ma Yu Cun, Jinzhou City, Shijiazhuang City, Hebei Province

Patentee before: HEBEI LANSHENG BIOTECH Co.,Ltd.